Pharmigene, Inc. (TPEX:7595)

Pharmigene Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.34	68.53	76.86	104.29	212.77
Short-Term Investments	31.96	38.81	118.73	134.8	84.71
Trading Asset Securities	34.34	53.43	-	-	-
Cash & Short-Term Investments	158.64	160.78	195.59	239.09	297.48
Cash Growth	-1.33%	-17.80%	-18.19%	-19.63%	202.55%
Accounts Receivable	12.87	25.66	27.43	17.31	12.67
Other Receivables	0.68	0.49	1.15	0.03	0.12
Receivables	13.55	26.15	28.58	17.34	12.79
Inventory	53.68	27.44	28.57	18.71	17.46
Prepaid Expenses	21.3	17.92	5.39	10.65	9.09
Other Current Assets	3.07	21.7	0.4	0.3	0.27
Total Current Assets	250.25	253.99	258.54	286.09	337.08
Property, Plant & Equipment	593.89	559.95	28.35	36.73	30.57
Long-Term Investments	16.3	86.11	67.18	70.81	63.4
Other Intangible Assets	13.44	14.07	14.03	15.96	6.3
Long-Term Deferred Tax Assets	-	-	-	-	0.02
Other Long-Term Assets	129.28	132.85	16.17	9.54	12.54
Total Assets	1,003	1,047	384.27	419.12	449.91
Accounts Payable	14.42	7.95	7.19	2.88	2.88
Accrued Expenses	10.18	11.37	10.06	7.92	6.92
Current Portion of Long-Term Debt	12.94	-	-	-	-
Current Portion of Leases	3.85	6.53	5.35	6.99	6.89
Current Income Taxes Payable	-	-	-	-	1.48
Current Unearned Revenue	3.72	2.01	9.07	2.74	3.9
Other Current Liabilities	7.39	8.85	6.64	4.31	1.73
Total Current Liabilities	52.51	36.72	38.3	24.84	23.81
Long-Term Debt	597.46	559.4	-	-	-
Long-Term Leases	2.23	5.16	4.09	7.75	14.74
Long-Term Deferred Tax Liabilities	-	-	-	0.01	-
Other Long-Term Liabilities	1.88	1.57	2.13	4.3	1.8
Total Liabilities	654.08	602.85	44.52	36.9	40.35
Common Stock	504.65	504.65	434.65	434.65	434.65
Additional Paid-In Capital	105	105	-	-	45.07
Retained Earnings	-251.34	-172.73	-100.09	-57.37	-79.01
Comprehensive Income & Other	-9.25	7.18	5.19	4.95	8.85
Shareholders' Equity	349.06	444.1	339.75	382.22	409.56
Total Liabilities & Equity	1,003	1,047	384.27	419.12	449.91
Total Debt	616.49	571.1	9.43	14.74	21.63
Net Cash (Debt)	-457.84	-410.32	186.16	224.35	275.85
Net Cash Growth	-	-	-17.02%	-18.67%	246.69%
Net Cash Per Share	-9.07	-9.02	4.28	5.16	8.15
Filing Date Shares Outstanding	50.47	50.47	43.47	43.47	43.47
Total Common Shares Outstanding	50.47	50.47	43.47	43.47	43.47
Working Capital	197.74	217.27	220.24	261.25	313.27
Book Value Per Share	6.92	8.80	7.82	8.79	9.42
Tangible Book Value	335.63	430.04	325.72	366.26	403.26
Tangible Book Value Per Share	6.65	8.52	7.49	8.43	9.28
Land	284.6	284.6	-	-	-
Buildings	281.35	250.31	8.67	-	-
Machinery	53.11	39.53	35.16	46.37	27.26
Construction In Progress	3.17	13.11	-	-	-
Leasehold Improvements	-	-	-	8.3	7
Order Backlog	-	-	-	-	3.9

Updated Aug 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.